| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.5M | -19.3% |
| Cost of Revenue | $20.2M | -23.2% |
| Gross Profit | $1.3M | +284.4% |
| R&D Expense | $3.3M | -15.7% |
| SG&A Expense | $13.1M | -28.0% |
| Operating Income | -$22.1M | +20.8% |
| Pre-tax Income | -$18.3M | +29.2% |
| Income Tax | -$268K | -397.8% |
| Net Income | -$18.0M | -124.1% |
| EPS (Basic) | -$0.79 | -125.2% |
| EPS (Diluted) | -$0.79 | -125.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.6M | -5.2% |
| Accounts Receivable | $4.1M | -3.4% |
| Inventory | $7.4M | -0.7% |
| Current Assets | $142.7M | -6.7% |
| Total Assets | $151.3M | -7.3% |
| Current Liabilities | $9.4M | +18.0% |
| Total Liabilities | $10.6M | +16.2% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.7M | +56.6% |
| Investing Cash Flow | -$810K | -100.6% |
| Financing Cash Flow | -$431K | +96.8% |
| $140.7M |
| -8.7% |